Chemotherapy and Granulocyte count decreased

Summary:

Granulocyte count decreased is found among people with Chemotherapy, especially for people who are female, 60+ old.

The study analyzes which people have Granulocyte count decreased with Chemotherapy. It is created by eHealthMe based on reports of 65 people who have Chemotherapy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Chemotherapy?

Chemotherapy is found to be associated with 226 drugs and 468 conditions by eHealthMe. Check the latest studies of Chemotherapy.

What is Granulocyte count decreased?

Granulocyte count decreased is found to be associated with 143 drugs and 335 conditions by eHealthMe. Check the latest studies of Granulocyte count decreased.



On Jul, 17, 2026

65 people who have Chemotherapy and Granulocyte Count Decreased are studied.

Would you have Granulocyte count decreased when you have Chemotherapy?

Gender of people who have Chemotherapy and experienced Granulocyte Count Decreased *:

  • female: 58.06 %
  • male: 41.94 %

Age of people who have Chemotherapy and experienced Granulocyte Count Decreased *:

  • 0-1: 1.72 %
  • 2-9: 8.62 %
  • 10-19: 22.41 %
  • 20-29: 10.34 %
  • 30-39: 3.45 %
  • 40-49: 10.34 %
  • 50-59: 18.97 %
  • 60+: 24.14 %

Common co-existing conditions for these people *:

  1. Breast Cancer Female: 4 people, 6.15%
  2. Tumor: 2 people, 3.08%
  3. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 3.08%
  4. Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 2 people, 3.08%
  5. Breast Cancer: 2 people, 3.08%
  6. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 3.08%
  7. Neuroblastoma (a cancer that forms in your nerve tissue): 1 person, 1.54%
  8. Neoplasm Malignant (cancer tumour): 1 person, 1.54%
  9. Myelosuppression (a decrease in the production of blood cells): 1 person, 1.54%
  10. Multiple Myeloma (cancer of the plasma cells): 1 person, 1.54%

Common drugs taken by these people *:

  1. Cytarabine: 23 people, 35.38%
  2. Cyclophosphamide: 17 people, 26.15%
  3. Sodium Chloride: 17 people, 26.15%
  4. Methotrexate Sodium: 11 people, 16.92%
  5. Epirubicin Hydrochloride: 7 people, 10.77%
  6. Methotrexate: 7 people, 10.77%
  7. Idarubicin Hydrochloride: 4 people, 6.15%
  8. Dexamethasone Sodium Phosphate: 4 people, 6.15%
  9. Zoladex: 3 people, 4.62%
  10. Dexrazoxane: 3 people, 4.62%

Common symptoms for these people *:

  1. White Blood Cell Count Decreased: 27 people, 41.54%
  2. Myelosuppression (a decrease in the production of blood cells): 26 people, 40.00%
  3. Thrombocytopenia (decrease of platelets in blood): 16 people, 24.62%
  4. Fever: 13 people, 20.00%
  5. Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 6 people, 9.23%
  6. Blood Creatinine Increased: 4 people, 6.15%
  7. Pneumonia: 3 people, 4.62%
  8. Haemoglobin Decreased: 3 people, 4.62%
  9. Neoplasm Progression (growth of tumour): 3 people, 4.62%
  10. Lymphocyte Count Decreased: 2 people, 3.08%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Granulocyte count decreased?

- Check whether Granulocyte count decreased is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Granulocyte count decreased:

All the conditions that are associated with Granulocyte count decreased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Granulocyte count decreased and Chemotherapy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: